MYCN and neuroblastoma: Recently, we reported improved outcome in such patients after primary chemotherapy including carboplatin and etoposide with a 90% survival rates and children with unresectable NB and no N-myc amplification fared as well as those undergoing primary surgery (Rubie et al, 1998).